evolcSign inStart free
Menu

NRG Therapeutics

Develops oral medicines for ALS, Parkinson’s and other neurodegenerative diseases

Stevenage, United KingdomFounded 2018nrgtherapeutics.comWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-10-31

About NRG Therapeutics

NRG Therapeutics is a clinical-stage neuroscience company developing oral, brain-penetrant small-molecule medicines. Its pipeline targets NLRX1 and mitochondrial dysfunction, with lead asset NRG5051 advancing through Phase 1 clinical trials for ALS and Parkinson’s.

The company is based in the UK and develops medicines for people with neurodegenerative diseases. It aims to advance clinical assets through proof-of-concept trials for later development and commercialization by global pharmaceutical partners.

NRG Therapeutics was founded in 2018 and is headquartered in Stevenage, United Kingdom. It is a private company backed by healthcare investors and disease foundations.

Product: Clinical-stage pipeline of oral small-molecule medicines targeting neurodegenerative diseases, including lead asset NRG5051.

Jobs at NRG Therapeutics

No open positions listed right now.

Leadership

More biotech & pharma companies

  • Nuclera

    Automated protein screening instrument and antibody triage services for protein scientists and biopharma labs
    Cambridge, United KingdomBiotech & pharmaFounded 20132 open jobs

  • OMass Therapeutics

    Drug discovery company developing small-molecule medicines for immunological and orphan diseases
    United KingdomBiotech & pharma1 open job
    New on Evolc

  • Optibrium

    Drug discovery software for pharmaceutical, biotech and academic teams designing and selecting small-molecule compounds
    Cambridge, United KingdomBiotech & pharmaFounded 20083 open jobs
    New on Evolc

  • Orchard Therapeutics

    Develops hematopoietic stem cell gene therapies for severe genetic diseases, with patients, families and clinicians as its audience
    United KingdomBiotech & pharma6 open jobs
    Remote-friendly

  • Oribiotech

    Automated bioreactor and manufacturing platform for cell and gene therapy developers and manufacturers
    London, United KingdomBiotech & pharmaFounded 2015
    New on Evolc

  • Orthoson

    Develops an injectable implant to restore spinal disc mechanics for people with degenerative disc disease and back pain
    Oxford, United KingdomBiotech & pharmaFounded 2015
    New on Evolc

All biotech & pharma companies →

Website technologies

Older, unverified list. Detection dates and supporting evidence are not yet available.

  • Cloudflare
  • CookieYes
  • Google Analytics 4
  • WordPress
  • jQuery